GLUSKIN ANNA E

Director at GENEREX BIOTECHNOLOGY CORP · on record since Aug 21, 2007
CEO and President at GENEREX BIOTECHNOLOGY CORP · on record since Sep 15, 2003
Director at EASTGATE BIOTECH CORP · on record since Jun 8, 2012
CEO at EASTGATE BIOTECH CORP · on record since Jun 8, 2012

Insider trading activity of GLUSKIN ANNA E

Transactions on record: 25; since Sep 15, 2003

Open-market buys: 12; $392.7K

Open-market sells: 0

Companies traded: 2; last filing Jan 21, 2015

Figures computed from official regulatory filings — .

Companies where GLUSKIN ANNA E has traded

EASTGATE BIOTECH CORP6 tx · $687.5K · Jan 21, 2015
GENEREX BIOTECHNOLOGY CORP19 tx · $6.9K · Mar 10, 2010

Track record of GLUSKIN ANNA E

Statistical track record

Free account

Open-market buys: 15

Last buy: Jan 5, 2015

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of GLUSKIN ANNA E

Co-insiders of GLUSKIN ANNA E

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
EASTGATE BIOTECH CORPListing on record	Jan 21, 2015	BuyD (derivative)	1,243,750	0.04 USD	$49.8K	Cluster	SEC
EASTGATE BIOTECH CORPListing on record	Jan 21, 2015	Buy	1,243,750	0.04 USD	$49.8K	conv 46Cluster	SEC
EASTGATE BIOTECH CORPListing on record	Jul 14, 2014	Buy	480,000	0.25 USD	$120K	conv 49Cluster	SEC
EASTGATE BIOTECH CORPListing on record	Jul 14, 2014	BuyD (derivative)	360,000	0.25 USD	$90K	Cluster	SEC
EASTGATE BIOTECH CORPListing on record	Mar 31, 2014	Buy	864,000	0.25 USD	$216K	conv 81ClusterUnusual size+1	SEC
EASTGATE BIOTECH CORPListing on record	Mar 31, 2014	BuyD (derivative)	648,000	0.25 USD	$162K	ClusterUnusual size+1	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	OtherD (derivative)	-250,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	AwardD (derivative)	250,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	OtherD (derivative)	-1,120,704	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	AwardD (derivative)	1,120,704	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	AwardD (derivative)	500,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	May 29, 2008	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Aug 21, 2007	Award	200,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Apr 7, 2005	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Apr 7, 2005	AwardD (derivative)	1,120,705	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Jan 23, 2004	Buy	500	1.71 USD	$855	conv 29	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Dec 3, 2003	Buy	500	1.56 USD	$780	conv 24	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 25, 2003	Buy	500	1.63 USD	$815	conv 26	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 20, 2003	Buy	500	1.65 USD	$825	conv 27	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	200	1.85 USD	$370	conv 52First in 12mo	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	500	1.81 USD	$905	conv 52First in 12mo	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	300	1.82 USD	$546	conv 52First in 12mo	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	500	1.82 USD	$910	conv 34	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	500	1.81 USD	$905	conv 34	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Sep 15, 2003	AwardD (derivative)	350,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
EASTGATE BIOTECH CORPListing on record	Jan 21, 2015	BuyD (derivative)	1,243,750	0.04 USD	$49.8K	Cluster	SEC
EASTGATE BIOTECH CORPListing on record	Jan 21, 2015	Buy	1,243,750	0.04 USD	$49.8K	conv 46Cluster	SEC
EASTGATE BIOTECH CORPListing on record	Jul 14, 2014	Buy	480,000	0.25 USD	$120K	conv 49Cluster	SEC
EASTGATE BIOTECH CORPListing on record	Jul 14, 2014	BuyD (derivative)	360,000	0.25 USD	$90K	Cluster	SEC
EASTGATE BIOTECH CORPListing on record	Mar 31, 2014	Buy	864,000	0.25 USD	$216K	conv 81ClusterUnusual size+1	SEC
EASTGATE BIOTECH CORPListing on record	Mar 31, 2014	BuyD (derivative)	648,000	0.25 USD	$162K	ClusterUnusual size+1	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	OtherD (derivative)	-250,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	AwardD (derivative)	250,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	OtherD (derivative)	-1,120,704	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	AwardD (derivative)	1,120,704	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Mar 10, 2010	AwardD (derivative)	500,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	May 29, 2008	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Aug 21, 2007	Award	200,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Apr 7, 2005	AwardD (derivative)	250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Apr 7, 2005	AwardD (derivative)	1,120,705	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Jan 23, 2004	Buy	500	1.71 USD	$855	conv 29	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Dec 3, 2003	Buy	500	1.56 USD	$780	conv 24	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 25, 2003	Buy	500	1.63 USD	$815	conv 26	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 20, 2003	Buy	500	1.65 USD	$825	conv 27	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	200	1.85 USD	$370	conv 52First in 12mo	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	500	1.81 USD	$905	conv 52First in 12mo	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	300	1.82 USD	$546	conv 52First in 12mo	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	500	1.82 USD	$910	conv 34	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Nov 12, 2003	Buy	500	1.81 USD	$905	conv 34	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Sep 15, 2003	AwardD (derivative)	350,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC